| scholarly article | Q13442814 |
| P50 | author | Helen Atherton | Q28323673 |
| Warwick Dunn | Q42869731 | ||
| David I Broadhurst | Q56429841 | ||
| Roy Goodacre | Q57058337 | ||
| Julian L Griffin | Q84304363 | ||
| P2860 | cites work | Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum | Q21145030 |
| A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology | Q21147058 | ||
| MetaboMiner--semi-automated identification of metabolites from 2D NMR spectra of complex biofluids | Q21284195 | ||
| MathDAMP: a package for differential analysis of metabolite profiles | Q21284242 | ||
| The Sequence of the Human Genome | Q22065842 | ||
| Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests | Q22673963 | ||
| Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease | Q24289214 | ||
| SMPDB: The Small Molecule Pathway Database | Q24644198 | ||
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 | ||
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury | Q24657261 | ||
| Global reconstruction of the human metabolic network based on genomic and bibliomic data | Q24677060 | ||
| Processing methods for differential analysis of LC/MS profile data | Q24813623 | ||
| Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry | Q27136845 | ||
| FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry | Q27807494 | ||
| Life with 6000 genes | Q27860877 | ||
| Statistical strategies for avoiding false discoveries in metabolomics and related experiments | Q27887473 | ||
| Proposed minimum reporting standards for chemical analysis | Q27921801 | ||
| A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations | Q28141411 | ||
| Modeling the heart--from genes to cells to the whole organ | Q28204527 | ||
| Gut flora in health and disease | Q28209082 | ||
| A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
| Metallomics: the concept and methodology | Q28244001 | ||
| Five years of progress in the Standardization of Proteomics Data 4th Annual Spring Workshop of the HUPO-Proteomics Standards Initiative April 23-25, 2007 Ecole Nationale Supérieure (ENS), Lyon, France | Q28251402 | ||
| Clathrate nanostructures for mass spectrometry | Q28254680 | ||
| Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress | Q28257571 | ||
| Metabolic profiles of cancer cells | Q28269762 | ||
| Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples | Q28284074 | ||
| Mass spectrometry sampling under ambient conditions with desorption electrospray ionization | Q28288035 | ||
| A common open representation of mass spectrometry data and its application to proteomics research | Q28291914 | ||
| Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases | Q28388335 | ||
| Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia | Q28469040 | ||
| Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity | Q28472357 | ||
| Coordinated concentration changes of transcripts and metabolites in Saccharomyces cerevisiae | Q28474514 | ||
| Metabolomics – the link between genotypes and phenotypes | Q28540942 | ||
| Metabolite profiling for plant functional genomics | Q28540952 | ||
| ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunit | Q28586801 | ||
| Response and recovery in the plasma metabolome tracks the acute LCMV-induced immune response | Q28727959 | ||
| Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era | Q29398873 | ||
| The large-scale organization of metabolic networks | Q29547498 | ||
| Hierarchical organization of modularity in metabolic networks | Q29618451 | ||
| Contradicted and initially stronger effects in highly cited clinical research | Q29620013 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Metabolomics, machine learning and modelling: towards an understanding of the language of cells. | Q30350782 | ||
| GMD@CSB.DB: the Golm Metabolome Database | Q30482803 | ||
| The biochemical profile of rat testicular tissue as measured by magic angle spinning 1H NMR spectroscopy. | Q30620923 | ||
| Warmr: a data mining tool for chemical data | Q30642554 | ||
| Ab initio prediction of metabolic networks using Fourier transform mass spectrometry data | Q30747131 | ||
| Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro. | Q30822802 | ||
| Evaluation of protocols for reproducible electrospray in-source collisionally induced dissociation on various liquid chromatography/mass spectrometry instruments and the development of spectral libraries | Q30874113 | ||
| Reflections on the application of 13C-MRS to research on brain metabolism | Q30886267 | ||
| Metabolomics by numbers: acquiring and understanding global metabolite data | Q30925430 | ||
| Genetic algorithm optimization for pre-processing and variable selection of spectroscopic data | Q30974264 | ||
| Multiple high-throughput analyses monitor the response of E. coli to perturbations | Q34578020 | ||
| The nature of systems biology | Q34582744 | ||
| Genetics. Getting closer to the whole picture. | Q34623402 | ||
| Multiobjective optimization in bioinformatics and computational biology | Q34624817 | ||
| Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine | Q34649328 | ||
| Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes | Q34737010 | ||
| Cardiolipin, the heart of mitochondrial metabolism. | Q34772063 | ||
| Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum | Q34930194 | ||
| Real-time metabolic imaging | Q34983950 | ||
| Standard reporting requirements for biological samples in metabolomics experiments: microbial and in vitro biology experiments. | Q35024710 | ||
| Genetic associations in large versus small studies: an empirical assessment | Q35070873 | ||
| Membrane lipids and cell death: an overview. | Q35744743 | ||
| Self-consistent metabolic mixture analysis by heteronuclear NMR. Application to a human cancer cell line | Q35758964 | ||
| Mass spectrometry in metabolome analysis. | Q35897249 | ||
| Making sense of the metabolome using evolutionary computation: seeing the wood with the trees | Q35982478 | ||
| NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition | Q35997364 | ||
| The Edinburgh human metabolic network reconstruction and its functional analysis | Q36052649 | ||
| In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling | Q36055611 | ||
| Gut microorganisms, mammalian metabolism and personalized health care | Q36094303 | ||
| Measuring the metabolome: current analytical technologies | Q36106252 | ||
| Metabonomic modeling of drug toxicity | Q36211265 | ||
| Lipid mediators regulating pain sensitivity | Q36228967 | ||
| The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements | Q36278011 | ||
| The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? | Q36428339 | ||
| Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis | Q36437188 | ||
| Metabonomics techniques and applications to pharmaceutical research & development | Q36484646 | ||
| Systems biology, metabolic modelling and metabolomics in drug discovery and development | Q36665669 | ||
| Membrane lipids as signaling molecules | Q36758107 | ||
| Biomarker discovery using high-dimensional lipid analysis | Q36758137 | ||
| Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century | Q36816026 | ||
| Higher criticism thresholding: Optimal feature selection when useful features are rare and weak | Q36908144 | ||
| Metabolomic analysis and signatures in motor neuron disease | Q36908588 | ||
| Recent advancements in comprehensive two-dimensional separations with chemometrics | Q36909719 | ||
| Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover | Q36942649 | ||
| A general framework for multiple testing dependence | Q36981995 | ||
| Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics | Q37004712 | ||
| Identification of small molecules from human embryonic stem cells using metabolomics | Q37016135 | ||
| Functional genomics and NMR spectroscopy | Q37017702 | ||
| NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology | Q37048627 | ||
| Role of Lipids in Brain Injury and Diseases | Q37051065 | ||
| Metabolomics and its application for non-invasive embryo assessment in IVF. | Q37091046 | ||
| Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes | Q37119577 | ||
| Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making | Q37128425 | ||
| A matter of fat: an introduction to lipidomic profiling methods | Q37155154 | ||
| Predicting metabolic biomarkers of human inborn errors of metabolism | Q37196179 | ||
| Prospects for clinical cancer metabolomics using stable isotope tracers | Q37201287 | ||
| Measurement of dietary exposure: a challenging problem which may be overcome thanks to metabolomics? | Q37213130 | ||
| New insights into cardiovascular and lipid metabolomics | Q37252898 | ||
| Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM) | Q37281258 | ||
| High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo | Q37345616 | ||
| Riboswitch RNAs: using RNA to sense cellular metabolism | Q37367676 | ||
| Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. | Q37374980 | ||
| Analytical strategies in lipidomics and applications in disease biomarker discovery | Q37398347 | ||
| Identification of double bond position in lipids: from GC to OzID. | Q37403927 | ||
| Natural product analysis over the last decades | Q37407178 | ||
| Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome | Q37412895 | ||
| Biomarkers in nutritional epidemiology: applications, needs and new horizons | Q37439416 | ||
| Database resources in metabolomics: an overview | Q37471556 | ||
| Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography | Q37488234 | ||
| Novel biological insights through metabolomics and 13C-flux analysis. | Q37595110 | ||
| Cellular imaging with secondary ion mass spectrometry | Q37617059 | ||
| An introduction to liquid chromatography-mass spectrometry instrumentation applied in plant metabolomic analyses | Q37635785 | ||
| Integrative biological analysis of the APOE*3-leiden transgenic mouse | Q38342071 | ||
| Bridging the gap between systems biology and medicine | Q38508961 | ||
| A new chemical diagnostic method for inborn errors of metabolism by mass spectrometry-rapid, practical, and simultaneous urinary metabolites analysis | Q38809078 | ||
| Characterization of the ABA-regulated global responses to dehydration in Arabidopsis by metabolomics | Q39543797 | ||
| Basic principles of ROC analysis | Q39680201 | ||
| High-resolution diffusion and relaxation-edited magic angle spinning 1H NMR spectroscopy of intact liver tissue | Q44637711 | ||
| Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. | Q44696001 | ||
| Simultaneous analysis of amino and nonamino organic acids as methyl chloroformate derivatives using gas chromatography-mass spectrometry | Q44713570 | ||
| Towards de novo identification of metabolites by analyzing tandem mass spectra | Q44805412 | ||
| Explanatory signal interpretation and metabolite identification strategies for nominal mass FIE-MS metabolite fingerprints | Q44840828 | ||
| Genetic algorithms for simultaneous variable and sample selection in metabonomics | Q45190729 | ||
| Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. | Q45207757 | ||
| Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy | Q45300208 | ||
| High temperature-ultra performance liquid chromatography-mass spectrometry for the metabonomic analysis of Zucker rat urine | Q45736396 | ||
| Probabilistic assignment of formulas to mass peaks in metabolomics experiments | Q45841427 | ||
| Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy | Q45855581 | ||
| Theodor Bücher Lecture. Metabolomics, modelling and machine learning in systems biology - towards an understanding of the languages of cells. Delivered on 3 July 2005 at the 30th FEBS Congress and the 9th IUBMB conference in Budapest. | Q45966124 | ||
| Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. | Q45966569 | ||
| (13)C-based metabolic flux analysis. | Q45991488 | ||
| Enhanced modification of cardiolipin during ischemia in the aged heart | Q46079907 | ||
| Understanding the human salivary metabolome | Q46101194 | ||
| Application of ultra performance liquid chromatography-mass spectrometry to profiling rat and dog bile | Q46103528 | ||
| Capillary electrophoresis-fourier transform ion cyclotron resonance mass spectrometry for the identification of cationic metabolites via a pH-mediated stacking-transient isotachophoretic method | Q46120944 | ||
| Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy | Q46127212 | ||
| Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy. | Q46153705 | ||
| A genome-scale, constraint-based approach to systems biology of human metabolism | Q46174580 | ||
| Analysis of the hibernation cycle using LC-MS-based metabolomics in ground squirrel liver | Q46184677 | ||
| Effective quenching processes for physiologically valid metabolite profiling of suspension cultured Mammalian cells | Q46211106 | ||
| Development of a multivariate statistical model to predict peroxisome proliferation in the rat, based on urinary 1H-NMR spectral patterns | Q46374978 | ||
| Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics | Q46407691 | ||
| A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols | Q46409977 | ||
| Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation. | Q46444407 | ||
| Metabolic characterization of distinct neuroanatomical regions in rats by magic angle spinning 1H nuclear magnetic resonance spectroscopy | Q46448614 | ||
| GC-MS with ethyl chloroformate derivatization for comprehensive analysis of metabolites in serum and its application to human uremia | Q46486517 | ||
| Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers | Q46523516 | ||
| Detection and identification of novel metabolomic biomarkers in preeclampsia | Q46585274 | ||
| Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules | Q46602251 | ||
| Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism | Q46670045 | ||
| Expanding metabolic networks: scopes of compounds, robustness, and evolution | Q46697439 | ||
| Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry | Q46771065 | ||
| Metabolomic profiling to develop blood biomarkers for Parkinson's disease | Q46789088 | ||
| Higher mass loadability in comprehensive two-dimensional gas chromatography-mass spectrometry for improved analytical performance in metabolomics analysis | Q46836233 | ||
| Metabolomic identification of novel biomarkers of myocardial ischemia | Q46847927 | ||
| Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity | Q47202557 | ||
| Systems biology: Metabonomics | Q47647280 | ||
| Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project | Q48008085 | ||
| Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models | Q48080119 | ||
| Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study. | Q48414747 | ||
| Impact of analytical bias in metabonomic studies of human blood serum and plasma. | Q48685223 | ||
| Multiparametric analysis of amino acids and organic acids in rat brain tissues using GC/MS. | Q49023412 | ||
| Time-domain Bayesian detection and estimation of noisy damped sinusoidal signals applied to NMR spectroscopy. | Q50916289 | ||
| Dynamic range and mass accuracy of wide-scan direct infusion nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry-based metabolomics increased by the spectral stitching method. | Q51000987 | ||
| Metabolic flux analysis at ultra short time scale: isotopically non-stationary 13C labeling experiments. | Q51088105 | ||
| Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. | Q51467955 | ||
| A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. | Q51494017 | ||
| Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. | Q51793325 | ||
| Spectral relative standard deviation: a practical benchmark in metabolomics | Q39880397 | ||
| Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells | Q39892207 | ||
| Cross-platform Q-TOF validation of global exo-metabolomic analysis: application to human glioblastoma cells treated with the standard PI 3-Kinase inhibitor LY294002. | Q39902728 | ||
| Live single-cell metabolomics of tryptophan and histidine metabolites in a rat basophil leukemia cell | Q39905869 | ||
| Analysis of the adult human plasma metabolome | Q40107287 | ||
| Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice | Q40223413 | ||
| A comprehensive urinary metabolomic approach for identifying kidney cancerr | Q40240301 | ||
| MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status | Q40276305 | ||
| Parallel analysis of transcript and metabolic profiles: a new approach in systems biology | Q41011091 | ||
| Analytical strategies for LC-MS-based targeted metabolomics | Q41824102 | ||
| Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. | Q42062389 | ||
| Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery | Q42636050 | ||
| Variable selection using iterative reformulation of training set models for discrimination of samples: application to gas chromatography/mass spectrometry of mouse urinary metabolites | Q42698289 | ||
| Evaluation of predicted network modules in yeast metabolism using NMR-based metabolite profiling | Q42907936 | ||
| Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse | Q43125313 | ||
| Bringing metabolomics data into the forefront of systems biology | Q43147920 | ||
| Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia. | Q43272404 | ||
| UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction | Q43284293 | ||
| Automated principal component-based orthogonal signal correction applied to fused near infrared-mid-infrared spectra of French olive oils | Q43298422 | ||
| Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics | Q43410367 | ||
| Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. | Q43571745 | ||
| Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue | Q43617337 | ||
| Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning (1)H NMR spectroscopy | Q43690917 | ||
| Bias as a threat to the validity of cancer molecular-marker research | Q44087175 | ||
| Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production | Q44102079 | ||
| High-resolution capillary tube NMR. A miniaturized 5-microL high-sensitivity TXI probe for mass-limited samples, off-line LC NMR, and HT NMR. | Q44139805 | ||
| Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy | Q44286768 | ||
| Derivatisation for liquid chromatography/electrospray mass spectrometry: synthesis of pyridinium compounds and their amine and carboxylic acid derivatives | Q44351563 | ||
| An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria | Q44405516 | ||
| Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry | Q44419229 | ||
| Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection | Q44492972 | ||
| Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography | Q44565769 | ||
| The application of LC-NMR and LC-SPE-NMR to compositional studies of natural organic matter | Q30977202 | ||
| Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets | Q30983576 | ||
| Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets | Q30988040 | ||
| Flow-injection electrospray ionization mass spectrometry of crude cell extracts for high-throughput bacterial identification | Q31038092 | ||
| Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum | Q31040233 | ||
| MeMo: a hybrid SQL/XML approach to metabolomic data management for functional genomics | Q31043404 | ||
| Centering, scaling, and transformations: improving the biological information content of metabolomics data | Q31043704 | ||
| Statistical search space reduction and two-dimensional data display approaches for UPLC-MS in biomarker discovery and pathway analysis | Q31047468 | ||
| Targeted profiling: quantitative analysis of 1H NMR metabolomics data | Q31047473 | ||
| Data-driven modelling of signal-transduction networks | Q31068825 | ||
| Effects of probiotic Lactobacillus paracasei treatment on the host gut tissue metabolic profiles probed via magic-angle-spinning NMR spectroscopy | Q31102230 | ||
| Data processing for mass spectrometry-based metabolomics | Q31110739 | ||
| High-throughput tissue extraction protocol for NMR- and MS-based metabolomics | Q31134369 | ||
| BioMagResBank (BMRB) as a partner in the Worldwide Protein Data Bank (wwPDB): new policies affecting biomolecular NMR depositions | Q31147274 | ||
| Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials | Q31170846 | ||
| Reproducible product-ion tandem mass spectra on various liquid chromatography/mass spectrometry instruments for the development of spectral libraries | Q33204181 | ||
| Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation | Q33231491 | ||
| Mass spectrometry-based metabolomics | Q33254576 | ||
| Metabolic profiling of patients with schizophrenia | Q33255317 | ||
| PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism | Q33283063 | ||
| Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach | Q33301559 | ||
| Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis | Q33304101 | ||
| The genome-scale metabolic model iIN800 of Saccharomyces cerevisiae and its validation: a scaffold to query lipid metabolism | Q33358522 | ||
| Cluster TOF-SIMS imaging: a new light for in situ metabolomics? | Q33361364 | ||
| MetaFIND: a feature analysis tool for metabolomics data. | Q33382868 | ||
| Metabolite profiling of fecal water extracts from human colorectal cancer | Q33384170 | ||
| Responsive MRI agents for sensing metabolism in vivo | Q33415333 | ||
| MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing | Q33420030 | ||
| Acid-base-driven matrix-assisted mass spectrometry for targeted metabolomics | Q33466661 | ||
| Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics | Q33475674 | ||
| Metabolite signal identification in accurate mass metabolomics data with MZedDB, an interactive m/z annotation tool utilising predicted ionisation behaviour 'rules'. | Q33484964 | ||
| Biomarkers of dietary energy restriction in women at increased risk of breast cancer. | Q33490898 | ||
| Pitfalls of supervised feature selection | Q33627547 | ||
| Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy | Q33675261 | ||
| Systematic functional analysis of the yeast genome | Q34067467 | ||
| Quantitative Metabolome Analysis Using Capillary Electrophoresis Mass Spectrometry | Q34272743 | ||
| Metabonomics in toxicology: a review | Q34390625 | ||
| GC-MS libraries for the rapid identification of metabolites in complex biological samples | Q34398084 | ||
| The emerging field of lipidomics | Q34438156 | ||
| Metabolomics and systems biology: making sense of the soup | Q34548620 | ||
| The role of analytical sciences in medical systems biology | Q34551383 | ||
| Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. | Q34572330 | ||
| Measurement of gluconeogenesis and pyruvate recycling in the rat liver: a simple analysis of glucose and glutamate isotopomers during metabolism of [1,2,3-(13)C3]propionate. | Q52259393 | ||
| An investigation of tumor 1H nuclear magnetic resonance spectra by the application of chemometric techniques | Q52409542 | ||
| Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. | Q52929104 | ||
| A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. | Q53588029 | ||
| High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. | Q53623717 | ||
| Global metabolic profiling of Escherichia coli cultures: an evaluation of methods for quenching and extraction of intracellular metabolites. | Q54425409 | ||
| Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. | Q55480476 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Standard reporting requirements for biological samples in metabolomics experiments: environmental context | Q56506588 | ||
| Development and Performance of a Gas Chromatography−Time-of-Flight Mass Spectrometry Analysis for Large-Scale Nontargeted Metabolomic Studies of Human Serum | Q56974372 | ||
| Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate | Q56974469 | ||
| Proposed minimum reporting standards for data analysis in metabolomics | Q56974474 | ||
| Metabolomic biomarkers: search, discovery and validation | Q56974486 | ||
| Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning | Q56974546 | ||
| A metabolome pipeline: from concept to data to knowledge | Q56974556 | ||
| A proposed framework for the description of plant metabolomics experiments and their results | Q56974576 | ||
| Metabolic profiling using direct infusion electrospray ionisation mass spectrometry for the characterisation of olive oils | Q56974624 | ||
| Classification of pyrolysis mass spectra by fuzzy multivariate rule induction-comparison with regression, K-nearest neighbour, neural and decision-tree methods | Q56974874 | ||
| Genetic algorithms as a method for variable selection in multiple linear regression and partial least squares regression, with applications to pyrolysis mass spectrometry | Q56974902 | ||
| Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling | Q56999824 | ||
| Bioinformatics and computational approaches applicable to lipidomics | Q57012233 | ||
| Automated work-flow for processing high-resolution direct infusion electrospray ionization mass spectral fingerprints | Q57020637 | ||
| Metabolome Analysis | Q57020658 | ||
| A Functional Analysis of Mouse Models of Cardiac Disease through Metabolic Profiling | Q57263427 | ||
| Data Mining and Knowledge Discovery with Evolutionary Algorithms | Q57597686 | ||
| Metabolic Profile Biomarkers of Metal Contamination in a Sentinel Terrestrial Species Are Applicable Across Multiple Sites | Q57664963 | ||
| Minimum reporting standards for plant biology context information in metabolomic studies | Q57783597 | ||
| Evaluation of automated electrospray-TOF mass spectrometryfor metabolic fingerprinting of the plant metabolome | Q57797903 | ||
| Metabolomics: Current analytical platforms and methodologies | Q57797930 | ||
| Metabolomics standards initiative: ontology working group work in progress | Q57803438 | ||
| Proposed reporting requirements for the description of NMR-based metabolomics experiments | Q57803446 | ||
| Statistical Correlation and Projection Methods for Improved Information Recovery from Diffusion-Edited NMR Spectra of Biological Samples | Q58045879 | ||
| Cryogenic Probe13C NMR Spectroscopy of Urine for Metabonomic Studies | Q58046078 | ||
| Metabolic profiling of rodent biological fluids via 1H NMR spectroscopy using a 1 mm microlitre probe | Q58046083 | ||
| Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins | Q58046285 | ||
| Comprehensive two-dimensional gas chromatography–time-of-flight mass spectrometry (GC × GC-TOF) for high resolution metabolomics: biomarker discovery on spleen tissue extracts of obese NZO compared to lean C57BL/6 mice | Q58809006 | ||
| Metabolite identification via the Madison Metabolomics Consortium Database | Q59013179 | ||
| Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects | Q59305041 | ||
| P433 | issue | 1 | |
| P921 | main subject | mass spectrometry | Q180809 |
| spectroscopy | Q483666 | ||
| P304 | page(s) | 387-426 | |
| P577 | publication date | 2010-08-17 | |
| P1433 | published in | Chemical Society Reviews | Q2962268 |
| P1476 | title | Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy | |
| P478 | volume | 40 |
| Q36472976 | (1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer |
| Q57658433 | 1H NMR Derived Metabolomic Profile of Neonatal Asphyxia in Umbilical Cord Serum: Implications for Hypoxic Ischemic Encephalopathy |
| Q30585535 | 1H NMR detection of small molecules in human urine with a deep cavitand synthetic receptor |
| Q57064146 | A Framework for Development of Useful Metabolomic Biomarkers and Their Effective Knowledge Translation |
| Q58762484 | A Metabolomics Approach to Pharmacotherapy Personalization |
| Q92652818 | A Metabolomics-Inspired Strategy for the Identification of Protein Covalent Modifications |
| Q93003602 | A Non-Targeted Capillary Electrophoresis-Mass Spectrometry Strategy to Study Metabolic Differences in an In vitro Model of High-Glucose Induced Changes in Human Proximal Tubular HK-2 Cells |
| Q90406862 | A Solution to Antifolate Resistance in Group B Streptococcus: Untargeted Metabolomics Identifies Human Milk Oligosaccharide-Induced Perturbations That Result in Potentiation of Trimethoprim |
| Q37699460 | A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis |
| Q91289189 | A comparative evaluation of the generalised predictive ability of eight machine learning algorithms across ten clinical metabolomics data sets for binary classification |
| Q52624666 | A metabolomic approach identifies differences in maternal serum in third trimester pregnancies that end in poor perinatal outcome. |
| Q89919373 | A microbiome and metabolomic signature of phases of cutaneous healing identified by profiling sequential acute wounds of human skin: An exploratory study |
| Q57797242 | A new strategy for MS/MS data acquisition applying multiple data dependent experiments on Orbitrap mass spectrometers in non-targeted metabolomic applications |
| Q36937203 | A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue |
| Q38066622 | A practical guide to metabolomic profiling as a discovery tool for human heart disease |
| Q39329687 | A review of blood sample handling and pre-processing for metabolomics studies. |
| Q89464106 | A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment |
| Q38201037 | A rough guide to metabolite identification using high resolution liquid chromatography mass spectrometry in metabolomic profiling in metazoans |
| Q39454414 | A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics. |
| Q33942420 | AMDORAP: non-targeted metabolic profiling based on high-resolution LC-MS. |
| Q42972901 | Adipose tissue and metabolic and inflammatory responses to stroke are altered in obese mice |
| Q38608766 | Advances in metabolome information retrieval: turning chemistry into biology. Part I: analytical chemistry of the metabolome. |
| Q88728905 | Ambient mass spectrometry in metabolomics |
| Q38980952 | Analytical strategies for studying stem cell metabolism |
| Q38543518 | Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens |
| Q28066467 | Application of Omics Technologies for Evaluation of Antibacterial Mechanisms of Action of Plant-Derived Products |
| Q64101685 | Application of metabolomics in viral pneumonia treatment with traditional Chinese medicine |
| Q24600728 | Applications of metabolomics in cancer research |
| Q90226879 | Associations between Blood Metabolic Profile at 7 Years Old and Eating Disorders in Adolescence: Findings from the Avon Longitudinal Study of Parents and Children |
| Q34164910 | Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets |
| Q30663335 | Batch profiling calibration for robust NMR metabonomic data analysis |
| Q37581290 | Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization |
| Q38759621 | Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics |
| Q34205992 | Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis |
| Q28652509 | Bioinformatics: the next frontier of metabolomics |
| Q64099328 | Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate |
| Q99634917 | Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches |
| Q41889856 | CASMI-The Small Molecule Identification Process from a Birmingham Perspective |
| Q98178095 | Changes in Amino Acid and Acylcarnitine Plasma Profiles for Distinguishing Patients with Multiple Sclerosis from Healthy Controls |
| Q36665685 | Characterisation of the main drivers of intra- and inter- breed variability in the plasma metabolome of dogs. |
| Q90704729 | Chronic Dysregulation of Cortical and Subcortical Metabolism After Experimental Traumatic Brain Injury |
| Q26742050 | Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era |
| Q57749233 | Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW |
| Q33745104 | Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls |
| Q38994528 | Commentary on "Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural networks". |
| Q28087689 | Computationally Modeling Lipid Metabolism and Aging: A Mini-review |
| Q34030471 | Cross-platform analysis of longitudinal data in metabolomics |
| Q41598901 | Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury |
| Q37986333 | Current applications of high-resolution mass spectrometry in drug metabolism studies. |
| Q37644820 | Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo |
| Q48225243 | Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences. |
| Q36412730 | Development of a Liquid Chromatography-High Resolution Mass Spectrometry Metabolomics Method with High Specificity for Metabolite Identification Using All Ion Fragmentation Acquisition. |
| Q57797336 | Diabetes - the Role of Metabolomics in the Discovery of New Mechanisms and Novel Biomarkers |
| Q39030360 | Direct infusion mass spectrometry for metabolomic phenotyping of diseases |
| Q30251871 | Discovery of biochemical biomarkers for aggression: A role for metabolomics in psychiatry |
| Q37728545 | Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry |
| Q35099056 | Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics |
| Q40047134 | Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing |
| Q48443602 | Early Cord Metabolite Index and Outcome in Perinatal Asphyxia and Hypoxic-Ischaemic Encephalopathy. |
| Q36441640 | Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial |
| Q41194548 | Elucidating the Structure of N1-Acetylisoputreanine: A Novel Polyamine Catabolite in Human Urine |
| Q38750312 | Emerging new strategies for successful metabolite identification in metabolomics. |
| Q64251629 | Evaluation of Sample Preparation Methods for the Analysis of Reef-Building Corals Using ¹H-NMR-Based Metabolomics |
| Q34128364 | Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. |
| Q92547501 | Examining the predictive accuracy of metabolomics for small-for-gestational-age babies: a systematic review |
| Q51347860 | Experimental and Study Design Considerations for Uncovering Oncometabolites. |
| Q37954705 | Exploring the metabolic state of microorganisms using metabolomics |
| Q38870183 | Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells |
| Q51335122 | Familial resemblance for serum metabolite concentrations. |
| Q96683546 | Fast and sensitive flow-injection mass spectrometry metabolomics by analyzing sample-specific ion distributions |
| Q34315897 | Fingerprinting food: current technologies for the detection of food adulteration and contamination |
| Q33931794 | Fish welfare and genomics |
| Q97415763 | Genetics and Not Shared Environment Explains Familial Resemblance in Adult Metabolomics Data |
| Q28258384 | Genome-wide association study identifies multiple loci influencing human serum metabolite levels |
| Q34322551 | Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. |
| Q33707386 | Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage |
| Q55408734 | Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. |
| Q33935505 | Hair metabolomics: identification of fetal compromise provides proof of concept for biomarker discovery. |
| Q47096026 | Hepatic Dysfunction Caused by Consumption of a High-Fat Diet. |
| Q54355166 | High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. |
| Q38835222 | Historical and contemporary stable isotope tracer approaches to studying mammalian protein metabolism |
| Q90683631 | How could metabolomics change pediatric health? |
| Q90477473 | Impact of matrix effects and ionization efficiency in non-quantitative untargeted metabolomics |
| Q48304997 | Improved Quantum Chemical NMR Chemical Shift Prediction of Metabolites in Aqueous Solution toward the Validation of Unknowns. |
| Q41460202 | In vivo and real-time monitoring of secondary metabolites of living organisms by mass spectrometry |
| Q88321932 | Insights into CKD from Metabolite GWAS |
| Q30774194 | Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data |
| Q45003414 | Integrating multiple analytical platforms and chemometrics for comprehensive metabolic profiling: application to meat spoilage detection. |
| Q38802998 | Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine. |
| Q37943853 | Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook |
| Q37000717 | Introduction to metabolomics and its applications in ophthalmology. |
| Q37731475 | Ion mobility derived collision cross sections to support metabolomics applications. |
| Q38151299 | Is 1H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity? |
| Q47294990 | JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance |
| Q34677433 | Large-scale metabolome analysis and quantitative integration with genomics and proteomics data in Mycoplasma pneumoniae. |
| Q36650424 | Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury |
| Q38554197 | Lipid and Metabolic Changes in Rheumatoid Arthritis. |
| Q45899917 | Magnetic susceptibility to measure total protein concentration from NMR metabolite spectra: Demonstration on blood plasma. |
| Q90277619 | Mass Spectrometry-Based Methodologies for Targeted and Untargeted Identification of Protein Covalent Adducts (Adductomics): Current Status and Challenges |
| Q27887476 | Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics |
| Q38424072 | Mass spectrometric based approaches in urine metabolomics and biomarker discovery |
| Q57803216 | Mass spectrometry based environmental metabolomics: a primer and review |
| Q30887960 | Maui-VIA: A User-Friendly Software for Visual Identification, Alignment, Correction, and Quantification of Gas Chromatography-Mass Spectrometry Data. |
| Q38107445 | Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk |
| Q89529703 | Metabolic Profiling in Blastocoel Fluid and Blood Plasma of Diabetic Rabbits |
| Q39891802 | Metabolic Profiling of Geobacter sulfurreducens during Industrial Bioprocess Scale-Up. |
| Q64997759 | Metabolic Profiling of the Diabetic Heart: Toward a Richer Picture. |
| Q44166748 | Metabolic changes associated with selenium deficiency in mice |
| Q99565628 | Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy |
| Q36316332 | Metabolic profiles of male meat eaters, fish eaters, vegetarians, and vegans from the EPIC-Oxford cohort |
| Q57706082 | Metabolic profiling of Daphnia magna exposed to environmental stressors by GC–MS and chemometric tools |
| Q38142255 | Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis |
| Q83498973 | Metabolic profiling of vitamin C deficiency in Gulo-/- mice using proton NMR spectroscopy |
| Q42372131 | Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge? |
| Q38816407 | Metabolic time-course response after resistance exercise: A metabolomics approach |
| Q97521749 | Metabolite AutoPlotter - an application to process and visualise metabolite data in the web browser |
| Q62020445 | Metabolite Identification in Complex Mixtures Using Nuclear Magnetic Resonance Spectroscopy |
| Q37080901 | Metabolites involved in glycolysis and amino acid metabolism are altered in short children born small for gestational age. |
| Q57797370 | Metabolomic analyses show that electron donor and acceptor ratios control anaerobic electron transfer pathways in Shewanella oneidensis |
| Q44115270 | Metabolomic analysis for first-trimester Down syndrome prediction |
| Q57749236 | Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results |
| Q42096841 | Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA). |
| Q64058719 | Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study |
| Q52596440 | Metabolomic markers of fertility in bull seminal plasma. |
| Q35325389 | Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction |
| Q37713233 | Metabolomic patterns associated to QTc interval in shiftworkers: an explorative analysis |
| Q28306726 | Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis |
| Q26849401 | Metabolomic profiling in perinatal asphyxia: a promising new field |
| Q41137046 | Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance |
| Q38445925 | Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes. |
| Q94465343 | Metabolomics Analysis of Mesenchymal Stem Cells |
| Q64252507 | Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases |
| Q33587291 | Metabolomics analysis identifies different metabotypes of asthma severity |
| Q26765930 | Metabolomics and Its Application to Acute Lung Diseases |
| Q57797380 | Metabolomics and Its Role in the Study of Mammalian Systems |
| Q28608661 | Metabolomics and Natural-Products Strategies to Study Chemical Ecology in Nematodes |
| Q51383635 | Metabolomics and first-trimester prediction of early-onset preeclampsia. |
| Q27144251 | Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery |
| Q38182692 | Metabolomics applied in neonatology |
| Q37935537 | Metabolomics as a tool for cardiac research |
| Q28831476 | Metabolomics enables precision medicine: "A White Paper, Community Perspective" |
| Q38048372 | Metabolomics explained to perinatologists and pediatricians |
| Q54717567 | Metabolomics in drug discovery and development. |
| Q35525760 | Metabolomics in the developmental origins of obesity and its cardiometabolic consequences |
| Q30401265 | Metabolomics investigation of recombinant mTNFα production in Streptomyces lividans |
| Q42076218 | Metabolomics network characterization of resuscitation after normocapnic hypoxia in a newborn piglet model supports the hypothesis that room air is better |
| Q39395469 | Metabolomics of Diabetes in Pregnancy |
| Q41403906 | Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature |
| Q47159586 | Metabolomics profiling reveals different patterns in an animal model of asphyxial and dysrhythmic cardiac arrest |
| Q51303575 | Metabolomics reveals the physiological response of Pseudomonas putida KT2440 (UWC1) after pharmaceutical exposure. |
| Q91174606 | Metabolomics signatures of acutely ill and short-term weight recovered women with anorexia nervosa |
| Q36159065 | Metabolomics, Lipidomics and Pharmacometabolomics of Human Hypertension |
| Q92570170 | Metabolomics-Based Studies Assessing Exercise-Induced Alterations of the Human Metabolome: A Systematic Review |
| Q38757603 | Metabolomics: A Primer |
| Q38551411 | Metabolomics: Applications and Promise in Mycobacterial Disease. |
| Q38141080 | Metabolomics: a new tool for the investigation of metabolic changes induced by cytomegalovirus |
| Q37876428 | Metabolomics: a second-generation platform for crop and food analysis |
| Q44401629 | Metabonomic analysis of rats with acute heart rejection |
| Q92829126 | Migrating from partial least squares discriminant analysis to artificial neural networks: a comparison of functionally equivalent visualisation and feature contribution tools using jupyter notebooks |
| Q35576902 | Mitochondrial responses to extreme environments: insights from metabolomics |
| Q24289470 | Molecular phenotyping of a UK population: defining the human serum metabolome |
| Q39430006 | Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS). |
| Q33640903 | Multi-omics approaches to disease |
| Q91597308 | Multiple metabolic pathways are predictive of ricin intoxication in a rat model |
| Q44130213 | Multiple metabolomics of uropathogenic E. coli reveal different information content in terms of metabolic potential compared to virulence factors |
| Q35734379 | NMR Metabolomics Analysis of Parkinson's Disease |
| Q34444673 | NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review |
| Q38591205 | NMR metabolomics of renal cancer: an overview |
| Q45944514 | NMR window of molecular complexity showing homeostasis in superorganisms. |
| Q36245518 | NMR-based metabolic profiling in healthy individuals overfed different types of fat: links to changes in liver fat accumulation and lean tissue mass |
| Q38119451 | NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis |
| Q57016043 | NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations |
| Q39202174 | Non-targeted metabolomics in sport and exercise science |
| Q36140947 | Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury |
| Q57095244 | Nuclear Magnetic Resonance technique in tumor metabolism |
| Q26772297 | Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications |
| Q26745425 | Nutritional Cognitive Neuroscience: Innovations for Healthy Brain Aging |
| Q58584826 | Onco-Multi-OMICS Approach: A New Frontier in Cancer Research |
| Q63865883 | Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case–control sets from EPIC |
| Q38433127 | Perinatal asphyxia: a review from a metabolomics perspective. |
| Q58854359 | Pharmacological Metabolomics in Trypanosomes |
| Q50042094 | Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism. |
| Q37272725 | Postgenomics diagnostics: metabolomics approaches to human blood profiling |
| Q33872077 | Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition |
| Q56974325 | Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry |
| Q36470225 | Profiling the metabolome changes caused by cranberry procyanidins in plasma of female rats using (1) H NMR and UHPLC-Q-Orbitrap-HRMS global metabolomics approaches. |
| Q45838767 | Proteomics and metabolomics: can they solve some mysteries of the newborn? |
| Q47652764 | Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies |
| Q31126519 | Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis |
| Q56982051 | Rapid metabolic screening of early zebrafish embryogenesis based on direct infusion-nanoESI-FTMS |
| Q38336321 | Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer |
| Q28076129 | Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis |
| Q92091974 | Reduced Glycolysis Contributed to Inhibition of Testis Spermatogenesis in Rats After Chronic Methamphetamine Exposure |
| Q35746368 | Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC. |
| Q47631118 | Secondary ion mass spectrometry imaging and multivariate data analysis reveal co-aggregation patterns of Populus trichocarpa leaf surface compounds on a micrometer scale |
| Q35106899 | Serum 1H-NMR metabolomic fingerprints of acute-on-chronic liver failure in intensive care unit patients with alcoholic cirrhosis |
| Q36654870 | Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis |
| Q41607194 | Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer |
| Q37499674 | Signal intensities derived from different NMR probes and parameters contribute to variations in quantification of metabolites |
| Q42424346 | Stable isotope-assisted metabolomics for network-wide metabolic pathway elucidation |
| Q33723563 | Stable isotope-labeling studies in metabolomics: new insights into structure and dynamics of metabolic networks |
| Q90224413 | Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis |
| Q48302864 | Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra. |
| Q31059198 | Synthetic biology: mapping the scientific landscape |
| Q38222622 | Systematic applications of metabolomics in metabolic engineering |
| Q37661327 | Systems toxicology: from basic research to risk assessment |
| Q57466939 | Systems vaccinology and big data in the vaccine development chain |
| Q35906724 | Targeted metabolomics |
| Q92669170 | Targeting redox metabolism: the perfect storm induced by acrylamide poisoning in the brain |
| Q92372126 | Tear Metabolomics in Dry Eye Disease: A Review |
| Q90813747 | The application of artificial neural networks in metabolomics: a historical perspective |
| Q38694550 | The choice of amniotic fluid in metabolomics for the monitoring of fetus health. |
| Q35072850 | The current state of drug discovery and a potential role for NMR metabolomics |
| Q34782469 | The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series) |
| Q35156452 | The food metabolome: a window over dietary exposure |
| Q37512764 | The future of NMR metabolomics in cancer therapy: towards personalizing treatment and developing targeted drugs? |
| Q36302559 | The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. |
| Q34915983 | The impact of blood on liver metabolite profiling - a combined metabolomic and proteomic approach |
| Q38764605 | The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer |
| Q38050514 | The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans |
| Q56974296 | The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy |
| Q34507011 | The metabolomic profile of umbilical cord blood in neonatal hypoxic ischaemic encephalopathy |
| Q41197580 | The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. |
| Q37368054 | The role of reporting standards for metabolite annotation and identification in metabolomic studies |
| Q38195470 | Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome |
| Q24598642 | Translational biomarker discovery in clinical metabolomics: an introductory tutorial |
| Q36066989 | Untargeted mass spectrometric approach in metabolic healthy offspring of patients with type 2 diabetes reveals medium-chain acylcarnitine as potential biomarker for lipid induced glucose intolerance (LGIT). |
| Q57471599 | Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis |
| Q43008829 | Validation of a dual LC-HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics |
| Q37890454 | What do 'omic technologies have to offer periodontal clinical practice in the future? |
| Q48851536 | Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. |
| Q35897656 | iMet-Q: A User-Friendly Tool for Label-Free Metabolomics Quantitation Using Dynamic Peak-Width Determination |
| Q57011782 | „Metabolomics“ in der Diabetesforschung |
Search more.